inhibit the amount of dihydrotestosterone (DHT) in your body, allowing
natural re-growth. This treatment is very effective in men with a mild to moderate
amount of hair loss, not solely in the temple area and results are usually
apparent after a few months; with significant improvements being recorded for
up to five years after beginning treatment.
Propecia, manufactured by Merck,
Sharp and Dohme (MSD), was introduced to treat this problem but the UK patent
expired in October 2014 and therefore other pharmaceutical companies could then
manufacture a much cheaper generic equivalent of Propecia, called finasteride 1mg.